Acyl-CoA:lysocardiolipin acyltransferase-1 (ALCAT1) catalyzes acylation of lysocardiolipin back to cardiolipin, an important step in cardiolipin remodeling. The present study reports the catalytic properties of ALCAT1 in vitro and its regulation by thyroid hormone status in mouse liver and heart. Recombinant ALCAT1 expressed in Sf9 cells preferred basic pH conditions and did not require divalent cations or integrity of the subcellular membrane for its enzymatic activity. Recombinant ALCAT1 was potently inhibited by ADP and ATP, but not by adenosine nucleotide analogs or other nucleotides, such as UTP and GTP, suggesting that ALCAT1 does not require ATP hydrolysis for its enzyme activity. In addition to cardiolipin, ALCAT1 also catalyzed acylation of other members of the polyglycerophospholipid family, including phosphatidylglycerol, a precursor for cardiolipin synthesis, and bis(monoacylglycero)phosphate, a structural isomer of lysophosphatidylglycerol and a metabolic intermediate of cardiolipin. These findings suggest that ALCAT1 plays a role in the remodeling of other polyglycerophospholipids. In support of a regulatory role of ALCAT1 in cardiolipin remodeling in response to oxidative stress, ALCAT1 expression in liver and heart was significantly downregulated in mice with hypothyroidism and upregulated in mice treated with thyroid hormone, which is known to stimulate mitochondrial activity, oxidative stress, and cardiolipin remodeling. cardiolipin remodeling; oxidative stress; reactive oxygen species; hyperthyroidism; monolysocardiolipin acyltransferase AMONG PHOSPHOLIPIDS, cardiolipin is a unique polyglycerophospholipid consisting of four fatty acyl chains dominated by linoleic acid (31). This distinct fatty acyl composition of cardiolipin is believed to be important for its biological functions. However, the enzymes involved in the de novo cardiolipin biosynthetic pathway lack the appropriate substrate selectivity, which has been confirmed by recent cloning of a human gene encoding the first mammalian cardiolipin synthase (CLS1) by us and others (8, 15, 21) . The cardiolipin remodeling process involves a deacylation-reacylation cycle or transacylation among different phospholipids (4, 34, 39). Recently, a gene encoding the first cardiolipin remodeling enzyme, acyl-CoA:lysocardiolipin acyltransferase-1 (ALCAT1), has been cloned and characterized (4). The ALCAT1 enzyme possesses CoA-dependent acyltransferase (AT) activity and recognizes monolysocardiolipin (MLCL) and dilysocardiolipin (DLCL) as substrates.
AMONG PHOSPHOLIPIDS, cardiolipin is a unique polyglycerophospholipid consisting of four fatty acyl chains dominated by linoleic acid (31) . This distinct fatty acyl composition of cardiolipin is believed to be important for its biological functions. However, the enzymes involved in the de novo cardiolipin biosynthetic pathway lack the appropriate substrate selectivity, which has been confirmed by recent cloning of a human gene encoding the first mammalian cardiolipin synthase (CLS1) by us and others (8, 15, 21) . The cardiolipin remodeling process involves a deacylation-reacylation cycle or transacylation among different phospholipids (4, 34, 39) . Recently, a gene encoding the first cardiolipin remodeling enzyme, acyl-CoA:lysocardiolipin acyltransferase-1 (ALCAT1), has been cloned and characterized (4) . The ALCAT1 enzyme possesses CoA-dependent acyltransferase (AT) activity and recognizes monolysocardiolipin (MLCL) and dilysocardiolipin (DLCL) as substrates.
Cardiolipin remodeling is also believed to play an important role in repairing damage from oxidative stress, a process also known as lipid peroxidation, in tissues that require high levels of mitochondrial activity, such as liver and heart. Cardiolipin is particularly sensitive to oxidative damage by reactive oxygen species (ROS) because of its high content in polyunsaturated fatty acids and its location near the site of ROS production. Consequently, defective cardiolipin remodeling is associated with the onset of various metabolic diseases, such as hyperthyroidism, that are characterized by increased levels of ROS (2, 12, 27, 28, 38) . Hyperthyroidism and hypothyroidism have been shown to reciprocally affect the level of oxidative stress, lipid peroxidation, and cardiolipin synthesis and remodeling (11, 13 ); yet, the underlying molecular mechanisms remain elusive. The identification and molecular cloning of the mammalian ALCAT1 have made it possible to study how cardiolipin remodeling by ALCAT1 is regulated by oxidative stress associated with hyperthyroidism.
In addition to cardiolipin and its deacylated metabolites, there are two other major classes of polyglycerophospholipids in mammalian tissues: PG and bis(monoglycerol)phosphate (BMP), also known as lysobisphosphatidic acid. PG is a precursor for the biosynthesis of cardiolipin and BMP (1, 7, 36) , and its synthesis and remodeling are coupled with the synthesis and remodeling of cardiolipin (6, 37) . A gene encoding the first lysophosphatidylglycerol acyltransferase has recently been identified and characterized by us (40) . BMP facilitates the transfer of cholesterol to membranes (18) and multivesicular liposomes (24) , although very little is known about the biochemical pathways involved in its biosynthesis and remodeling. BMP is a structure isomer of PG, and its synthesis has recently been shown to be coupled with that of PG (16) . The fact that all three classes of polyglycerophospholipids are anionic phospholipids that possess a bisglycerolphosphate scaffold raises an interesting question: Could the ALCAT1 enzyme also regulate the remodeling of PG and BMP? In the present study, we examined catalytic properties of the recombinant ALCAT1 expressed in Sf9 cells: its structure selectivity toward different lysophospholipids and regulation by thyroid hormone status in liver and heart. Animals. Male C57BL/6 mice (4 -6 wk old; Harlan Laboratories, Indianapolis, IN) were maintained in an environmentally controlled facility with a diurnal light cycle and free access to food and water for Ն1 wk before use. Hyperthyroidism was induced by treatment with T4 for 5 consecutive days (250 g ⅐ day Ϫ1 ⅐ kg Ϫ1 ip). Hypothyroidism was generated in mice by administration of 0.05% 6-n-propyl-2-thiouracil (PTU) in the drinking water for 35 days. Control mice received an intraperitoneal injection of saline or were maintained on tap water ad libitum. On the last day of the treatments, animals were killed with CO2. Hearts and livers are removed and immediately frozen in liquid N 2 before storage at Ϫ70°C for later use for mRNA isolation. All animal procedures were in compliance with approved institutional animal care and use protocols according to National Institutes of Health guidelines (NIH publication no. 1985) .
Expression of ALCAT1 in insect cells. ALCAT1 expression in insect cells was determined as previously described (4) . Cells were typically infected with virus for 3 days, harvested in ice-cold phosphate-buffered saline, and homogenized in 20 mM NaCl with 10 up-and-down strokes in a motor-driven Dounce homogenizer (Heidolph) followed by 10 passages through a 27-gauge needle. Cell homogenates were immediately subjected to enzyme assays or frozen at Ϫ80°C for later use. Under certain circumstances, microsomal membranes were prepared for enzymatic analysis by a differential centrifugation process. Briefly, whole cell lysates were first centrifuged at 8,000 g to get rid of nuclear and mitochondrial membrane. Then, the supernatant was collected and centrifuged at 100,000 g to obtain microsomal membranes. The protein concentration in homogenates and membrane preparation was determined by a bicinchoninic acid protein assay kit (Pierce Biotechnology) according to the manufacturer's instructions.
In vitro assays for acyl-CoA-dependent AT activity. ALCAT was determined by measurement of incorporation of radiolabeled acyl moieties of acyl-CoAs (acyl donors) into phospholipids in the presence of various lysophospholipids, including MLCL, DLCL, lyso-PG (LPG), lyso-bis(monoacylglycero)phosphate (lyso-BMP), lysophosphatidic acid (LPA), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), lysophosphatidylserine (LPS), and lysoplatelet-activating factor (lyso-PAF). Unless indicated otherwise, the enzyme reactions were conducted in a buffer containing 50 mM Tris ⅐ HCl (pH 7.0), 200 M lysophospholipids, 20 M [ 14 C]acyl-CoA (50 mCi/mmol; American Radiolabeled Chemicals), and recombinant ALCAT in protein lysate (50 g) in a total volume of 100 l. The indicated concentration of divalent cations, nucleotides, or other inhibitors and activators was delivered into reactions together with substrates. The reaction was incubated at room temperature for 15 min. Lipids were extracted by sequential addition of 2 ml of chloroform-methanol (2:1, vol/vol) and 0.25 ml of 0.9% KCl. The reaction was vortexed vigorously and then briefly centrifuged, and aliquots of the organic phase (bottom) were dried under a speed vacuum and separated by a Linear-K Preadsorbent TLC plate (Whatman, Clifton, NJ) with chloroform-methanol-water (65:25:4, vol/vol/vol). After separation, TLC plates were exposed to a PhosphorImager screen for visualization of the radiolabeled products using a Molecular Dynamics STORM 860 Scanner (Sunnyvale, CA). The enzymatic products were identified with authentic standards by exposure to I2 vapor. Absolute enzymatic activity (pmol ⅐ min Ϫ1 ⅐ mg protein Ϫ1 ) was calculated by scraping radiolabeled phospholipids into scintillation vials followed by scintillation counting with a Beckman LS 6500 scintillation system (Fullerton, CA). All quantitative data are expressed as means Ϯ SE. Statistical analyses for differences between two groups were carried out using Student's t-test.
Northern blot and quantitative RT-PCR analysis. mRNA was directly isolated from frozen mouse tissues by use of a PloyA-Tract System-1000 according to the manufacturer's instructions (Promega, Madison, WI). Two micrograms of mRNA were separated in a 1% agarose-formaldehyde 3-(N-morpholino) propanesulfonic acid gel and transferred to a nylon membrane blot. The membrane was hybridized with [␣-
32 P]dCTP (3,000 Ci/mmol; ICN Radiochemicals)-labeled probes prepared from the full-length cDNA of mouse ALCAT1 using a random primers DNA labeling system (Invitrogen, Carlsbad, CA). The membranes were hybridized in ULTRAhyb (Ambion, Austin, TX) at 42°C overnight and then washed twice at 55°C in 2ϫ saline-sodium citrate buffer containing 0.1% SDS and 1 mM EDTA. Blots were stripped with boiling 1% SDS to remove radiolabeled probes and reprobed with the S9 ribosome protein cDNA as an internal control. The blots were exposed to a PhosphorImager screen, and radioactive signals were quantified by Molecular Dynamics. For quantitative PCR, 2 g of total RNA isolated from frozen tissues by use of the RNeasy Midi kit (Qiagen, Valencia, CA) were reverse transcribed to cDNA with TaqMan reverse transcription reagents (Applied Biosystems, Foster City, CA). Taqman real-time quantitative PCR was performed in a Prism 7900 (Applied Biosystems) using ALCAT1-specific primers and 18S primers (internal control) in the presence of 100 ng of cDNA as templates. Relative expression was determined by the cycle threshold (C t) method as suggested by Applied Biosystems.
RESULTS

Effect of pH, detergents, and divalent cations on AT activities of the recombinant ALCAT1 expressed in Sf9 cells.
The catalytic property of the recombinant ALCAT1 was investigated using MLCL and oleoyl-CoA as substrates. ALCAT1 is a positively charged protein with an isoelectric point of 8.5, and cardiolipin is an acidic phospholipid. The effect of pH on ALCAT1 activity was measured by assay of ALCAT1 enzyme in 50 mM Tris buffers at pH 4.0 -11.0, at 0.5-unit intervals. As shown in Fig. 1 , ALCAT1 preferred basic conditions for its enzymatic activity and demonstrated optimum activity at pH 7.0. The recombinant enzyme was quite resistant to alkaline conditions and remained active at pH 11.0. Conversely, the ALCAT1 enzyme showed high sensitivity to an acidic reaction condition and lost the majority of its activity starting at pH 6.0 (Fig. 1) .
Detergents are known to affect AT activity, such as acylCoA:monoacylglycerol AT and acyl-CoA:diacylglycerol AT, as previously shown by us and others (3, 19) . Treatment of cell lysates containing recombinant ALCAT1 with the nonionic detergents CHAPS and Triton X-100 resulted in concentrationdependent increases of ALCAT activity at concentrations up to 2%, whereas the enzyme lost the majority of its activity when incubated with Ͼ0.1% SDS (Fig. 2) . To investigate a role of divalent cations in regulating ALCAT activity, we measured ALCAT1 AT activity in the presence or absence of 4 mM Mg 2ϩ and Ca 2ϩ . As shown in Fig. 2 , addition of Mg 2ϩ and Ca 2ϩ to the reaction inhibited ALCAT1 activity by 40%, whereas EDTA, an Mg 2ϩ and Ca 2ϩ chelator, significantly activated MLCL AT activity, suggesting that the ALCAT1 enzyme does not require divalent cations for its enzyme activity.
ALCAT1 was potently inhibited by ATP and ADP, but not by nonhydrolyzable analogs and other nucleotides. Cardiolipin plays an important role in mitochondrial oxidative phosphorylation and, therefore, the synthesis of ATP. Cardiolipin is required for the reconstituted activity of ATP/ADP carrier proteins (29) and is known to affect DNA replication in bacteria by competing for the binding of ATP and ADP with the bacterial replication protein DnaA (33) . To investigate a role of ATP in regulating ALCAT1 enzyme activity, the recombinant ALCAT1 enzyme was analyzed for its enzyme activity against MLCL and [
14 C]oleoyl-CoA as substrates in the presence of 4 mM adenosine or other nucleotides and their analogs. ALCAT enzyme activity was inhibited by Ͼ95% and 90% by addition of 4 mM ADP and ATP, respectively. The inhibitory effect was specific, since addition of ADP␥S, a nonhydrolyzable ADP analog, to the enzyme reaction was without effect, whereas the nonhydrolyzable ATP analog ATP␥S and AMP-PNP moderately stimulated ALCAT activity (Fig. 3) . Similarly, addition of GTP or UTP did not have significant effects on the enzyme activity of the recombinant ALCAT1.
Substrate selectivity of ALCAT1 toward lysophospholipids.
Cardiolipin shares structural similarity with other polyglycerophospholipids, including PG and BMP, all of which consist of a bisglycerolphosphate backbone. These polyglycerophospholipids provide a structure diversity to further investigate the structure-activity relationship of ALCAT1 to different lysopolyglycerophospholipids. The AT reactions were carried out in the presence of 20 M [ 14 C]oleoyl-CoA as acyl donor and various lysophospholipids at 200 M as acyl acceptors, with the recombinant ALCAT1 expressed in Sf9 cells used as a source of enzyme. In addition to MLCL and DLCL (Fig. 4, A and B) , the recombinant ALCAT1 also recognized LPG and lyso-BMP as acyl acceptors (Fig. 4, C and D) , as evidenced by a significant increase in the formation of radiolabeled PG and BMP. However, under similar assay conditions, overexpression of ALCAT1 resulted in no increase in AT activity toward LPC, LPE, LPS, lyso-PAF, or LPI, compared with background levels (Fig. 4E) . Consistent with our previous finding (4), the recombinant ALCAT1 also exhibited LPA AT activity (Fig. 4E) . The substrates (LPA, MLCL, DLCL, LPG, and BMP) recognized by ALCAT1 share a common feature: they are anionic lysophospholipids. With the exception of LPA, it appears that ALCAT1 recognizes lysopolyglycerophospholipids as substrates. Substitution with a nonglycerol head (boxed area in Fig. 4E ) on the phosphate group led to a loss of recognition by ALCAT1 as a substrate.
Hepatic and cardiac expression of ALCAT1 mRNA was upregulated in mice treated with thyroid hormone. Thyroid hormone has a profound effect on mitochondrial activity and generation of ROS. Elevated hepatic and cardiac cardiolipin content in T 4 -treated rats is accompanied by an increase in CLS activity and level of ROS (5, 14) . Thyroid hormone is also known to stimulate mitochondrial activity as well as lipid peroxidation caused by ROS (11, 32) . To investigate a role of ALCAT1 in cardiolipin remodeling under hyperthyroid and hypothyroid states, we next investigated whether hepatic and cardiac expression of ALCAT1 mRNA expression is altered in mice treated with T 4 or PTU, a reagent that causes hypothyroidism. Consistent with the pathophysiological effects of thyroid hormone on the cardiovascular system, heart weight and heart weight-to-body weight ratio were significantly increased in mice treated with T 4 (250 g ⅐ day Ϫ1 ⅐ kg Ϫ1 for 5 consecutive days) compared with mice treated with normal saline: 142 Ϯ 28 vs. 118 Ϯ 7 mg and 6.2 Ϯ 1.2 vs. 4.7 Ϯ 0.5, respectively. As a result, the expression of ALCAT1 mRNA was significantly elevated in heart and liver of mice pretreated with T 4 compared with control mice (Fig. 5, left) , suggesting an important role of ALCAT1 in cardiolipin remodeling and mitochondrial activity in hyperthyroidism.
Conversely, ALCAT1 mRNA expression was decreased by 48% in heart and by 33% in liver (Fig. 5, right) , in mice in which hypothyroidism was induced by addition of PTU to drinking water. Consistent with the changes in ALCAT1 mRNA expression level as observed in our study, cardiac MLCL AT activity was reported to be increased by 60% in hyperthyroid rats treated with T 4 (25) and decreased by 35% in rats in which hypothyroidism was generated (35) . Our data suggest that the changes in MLCL AT activity may be attributed to alteration of ALCAT1 expression levels under different thyroid status. These findings also suggest an important role of ALCAT1 in cardiolipin remodeling in response to increased mitochondrial activity and ROS associated with hyperthyroidism.
DISCUSSION
ALCAT1 is a newly identified AT that catalyzes consecutive acylation of DLCL to MLCL and then to cardiolipin. The remodeling process is believed to be important to achieve the unique acyl composition of the four fatty acyl chains, which is restricted to C 18 chains dominated by the linoleoyl group (C18:2) (31), because the enzymes of the cardiolipin biosynthetic pathway lack appropriate substrate selectivity (15) . The reacylation of lysocardiolipin back to cardiolipin can also prevent the accumulation of MLCL, which was recently shown to cause apoptosis by binding to the proapoptotic factor tBid (20) . Furthermore, the remodeling process is also believed to repair damage to the double bonds of its side chains, also known as lipid peroxidation, by oxidative stress associated with metabolic diseases. To better understand a regulatory role of ALCAT1 cardiolipin remodeling and its physiological functions, we investigated the factors that affect ALCAT1 enzyme activity in vitro, structure selectivity toward various lysophospholipids, and its regulation by thyroid hormone status in mouse liver and heart, the predominant tissues of ALCAT1 expression.
The transfer of a fatty acyl group from acyl-CoA to lysocardiolipin catalyzed by the recombinant ALCAT1 exhibited an optimum pH of 7.0 but showed strong resistance to alkaline conditions even at pH 11.0. This may reflect the intrinsic properties of the enzyme and its substrates. ALCAT1 is a positively charged protein with an isoelectric point of 8.5, whereas cardiolipin is negatively changed. This pH profile is also similar to that of CLS but is quite distinct from that of the previously purified mitochondrial MLCL AT, which preferred acidic pH with an isoelectric point of 5.4 (34) . Furthermore, ALCAT1 differs from the mitochondrial MLCL AT in sensitivity to detergent treatment. Treatment with 2% CHAPS or Triton X-100 stimulated ALCAT1 activity, suggesting that ALCAT1 activity is not required for integrity of the subcellular membrane, where it resides. In contrast, mitochondrial MLCL AT from rat heart was inhibited by Ͼ50% in the presence of CHAPS and Triton X-100 at very low concentration (0.05%) (23) , further suggesting that the MLCL AT and ALCAT1 are likely encoded by two different genes.
In addition to DLCL and MLCL, ALCAT1 also recognized other lysophospholipids as substrates, including LPG and BMP. The common feature shared by this class of polyglycerophospholipids is the presence of a bisglycerolphosphate scaffold, which seems to be the required structure for recognition by ALCAT1. PG is a precursor for the biosynthesis of cardiolipin and BMP (1, 7, 36) . Consequently, defective cardiolipin remodeling in BTHS is associated with linoleic acid deficiency in PG and cardiolipin (37) . Additionally, the remodeling of PG by ALCAT1 may facilitate its use as a substrate for cardiolipin synthesis, since CLS demonstrates a partial preference for PG with C18:1/C18:2 moieties, but not for cytidine diphosphate-diacylglycerols (15) . BMP is a phospholipid initially identified in macrophages and has been shown to facilitate the transfer of cholesterol to membranes (18) , whereas semi-BMP may play a role in regulating the structure and function of the Golgi network (9) . Consequently, defective synthesis and remodeling of BMP are associated with the onset of neuronal and lipid storage diseases (10, 17, 30) . However, the biochemical steps involved in the synthesis and remodeling of BMP have not been fully elucidated. Thus the recognition by ALCAT1 of BMP suggests that this enzyme might play a role in the metabolism of BMP. The recognition of LPG and BMP as substrates by ALCAT1 is further supported by a recent report that BMP is coupled with PG (16). Ultimately, Fig. 5 . Reciprocal regulation of ALCAT1 expression by thyroxine (hyperthyroidism) and 6-n-propyl-2-thiouracil (PTU; hypothyroidism) in mouse liver and heart. mRNA levels of ALCAT1 were analyzed by Northern blot analysis (hyperthyroidism) or quantitative PCR (hypothyroidism). Values are means Ϯ SE. *P Ͻ 0.05 vs. control. the in vivo function of this enzyme awaits for the generation and phenotypic characterization of mice with targeted deletion of the ALCAT1 gene.
One interesting observation from the present study is the negative effect of ATP and ADP on the enzyme activity of ALCAT1. Cardiolipin is almost exclusively distributed in the mitochondrial membrane, where it is required for the reconstituted activity of a number of metabolic enzymes involved in oxidative phosphorylation, including ATP/ADP carrier proteins (29) . Consequently, cardiolipin deficiency from disruption of a CLS gene in yeast or from PG deficiency in Chinese hamster ovary cells results in mitochondrial dysfunction and reduced ATP production (26) . Accordingly, the inhibitory effect of ATP on ALCAT1 enzyme activity could serve as a feedback response to an increase in mitochondrial activity by modulating the acyl composition of cardiolipin. This notion is supported by the observation that ALCAT1 expression was potently regulated by hypothyroidism and hyperthyroidism, which adversely affect mitochondrial activity. Cardiolipin also plays a major role in regulating cell growth and apoptosis in Escherichia coli and mammalian cells. Cardiolipin regulates DNA replication in E. coli by competing for binding with ATP/ADP to DnaA, an ATPase involved in DNA replication (33) , whereas accumulation of lysocardiolipin triggers apoptosis in mammalian cells by binding to tBid, an apoptotic regulator (22) . It can be envisaged that regulation of ALCAT1 activity by ATP/ADP could play a role in apoptosis by modulating the level of lysocardiolipin.
Cardiolipin remodeling is also believed to repair damage of its acyl content from oxidative stress and to prevent accumulation of peroxidized cardiolipin. Cardiolipin is particularly sensitive to oxidative damage by ROS because of its high content in polyunsaturated fatty acids and its location near the site of ROS production. The appropriate acyl composition of cardiolipin is important for its biological functions in the mitochondria. Consequently, defective cardiolipin remodeling is associated with the onset of various metabolic diseases characterized by increased levels of ROS (2, 12, 27, 28, 38) . Additionally, the levels of cardiolipin and its lipid composition were profoundly altered by thyroid hormone, a major regulator of mitochondrial oxidative phosphorylation and lipid peroxidation in the heart (11) . In support of a role of ALCAT1 in regulating cardiolipin remodeling in response to increased levels of ROS, ALCAT1 expression was significantly upregulated in liver and heart of mice with hyperthyroidism, which increases ROS production. Conversely, ALCAT1 expression was significantly downregulated by hypothyroidism in mouse liver and heart. Our data are further corroborated by previous observations that T 4 treatment resulted in an increase in hepatic and cardiac cardiolipin content as well as activities of CLS and MLCL AT in the mitochondria (5, 14, 25) . Therefore, an increase in ALCAT1 expression would fulfill an increased need for cardiolipin remodeling in response to increased mitochondrial activity and ROS levels associated with hyperthyroidism.
